Literature DB >> 22785417

α-SMA overexpression associated with increased liver fibrosis in infants with biliary atresia.

Rui Dong1, Yi Luo, Shan Zheng.   

Abstract

OBJECTIVE: The mechanisms responsible for increased collagen production and hepatic fibrosis in biliary atresia (BA) remain largely unknown. We evaluated α-smooth muscle actin (α-SMA) expression in liver and the porta hepatis in infants with BA.
METHODS: Immunohistochemical staining for α-SMA and CD68 in the BA liver and porta hepatis was performed. A semiquantitative 3-grade staging system was employed to estimate liver fibrosis. The densities of CD68 in BA liver and the levels of direct bilirubin were assessed in relation to α-SMA expression.
RESULTS: α-SMA was found to be overexpressed in epithelial cells and in periductular collagen fibers. The expression in infants with BA was higher than that in the control group (P < 0.05). The amount of α-SMA in BA was positively correlated with liver fibrosis scores (r = 0.549, P = 0.022). The levels of α-SMA in the liver of BA were negatively related with improvements in direct bilirubin levels, 3 months postoperatively (r = -0.653, P = 0.029). The correlation between the α-SMA and CD-68 expression was not significantly different (r = 0.444, P = 0.057).
CONCLUSIONS: The expression of α-SMA in BA liver is higher than that in contro1 group. α-SMA expression is negatively correlated with the reduction of direct bilirubin, 3 months postoperatively, probably due to fibrosis or cirrhosis affecting the entire biliary system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22785417     DOI: 10.1097/MPG.0b013e3182680be3

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  8 in total

Review 1.  Biliverdin reductase and bilirubin in hepatic disease.

Authors:  Lauren Weaver; Abdul-Rizaq Hamoud; David E Stec; Terry D Hinds
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-01       Impact factor: 4.052

2.  Gene expression profiling of extrahepatic ducts in children with biliary atresia.

Authors:  Jiang Wang; Wei Wang; Rui Dong; Rui Zhao; Zhu Jin; Wenjun Shen; Shan Zheng
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Myofibroblastic cell activation and neovascularization predict native liver survival and development of esophageal varices in biliary atresia.

Authors:  Janne S Suominen; Hanna Lampela; Päivi Heikkilä; Jouko Lohi; Hannu Jalanko; Mikko P Pakarinen
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

4.  RNA-seq reveals outcome-specific gene expression of MMP7 and PCK1 in biliary atresia.

Authors:  Priya Ramachandran; Deepak Balamurali; J John Peter; M Milner Kumar; Mohamed Safwan; Mukul Vij; Mohamed Rela; Sundarasamy Mahalingam
Journal:  Mol Biol Rep       Date:  2019-07-24       Impact factor: 2.316

5.  5-O-Demethylnobiletin Alleviates CCl4-Induced Acute Liver Injury by Equilibrating ROS-Mediated Apoptosis and Autophagy Induction.

Authors:  Sukkum Ngullie Chang; Se Ho Kim; Debasish Kumar Dey; Seon Min Park; Omaima Nasif; Vivek K Bajpai; Sun Chul Kang; Jintae Lee; Jae Gyu Park
Journal:  Int J Mol Sci       Date:  2021-01-22       Impact factor: 5.923

6.  Unsupervised Clustering Reveals Distinct Subtypes of Biliary Atresia Based on Immune Cell Types and Gene Expression.

Authors:  Xiuqing Pang; Jing Cao; Shuru Chen; Zhiliang Gao; Guangjian Liu; Yutian Chong; Zhuanggui Chen; Jiao Gong; Xinhua Li
Journal:  Front Immunol       Date:  2021-09-27       Impact factor: 7.561

7.  Diagnostic value of anti-smooth muscle antibodies and liver enzymes in differentiation of extrahepatic biliary atresia and idiopathic neonatal hepatitis.

Authors:  Mandana Rafeey; Lida Saboktakin; Jamshid Shoa Hasani; Shahnaz Naghashi
Journal:  Afr J Paediatr Surg       Date:  2016 Apr-Jun

8.  α-Smooth muscle actin expression predicts the outcome of Kasai portoenterostomy in biliary atresia.

Authors:  Priya Ramachandran; Ashitha K Unny; Mukul Vij; Mohamed Safwan; Muthukrishnan Saravana Balaji; Mohamed Rela
Journal:  Saudi J Gastroenterol       Date:  2019 Mar-Apr       Impact factor: 2.485

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.